Elutia Inc. (ELUT) stock
ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$0.82−0.06 (-6.69%)
Close on Nov 13, 2026Market cap $36.32MP/E –Yield –
Elutia enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Elutia's enterprise value was $21.84M on Nov 11, 2026, against $52.56M a year earlier. Over the last 5 years it ranged from $10.51M to $111.44M, with a median of $60.70M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $21.84M | -61.0% |
| 2025 | Dec 31, 2025 | $56.01M | -42.6% |
| 2024 | Dec 31, 2024 | $97.49M | +139.9% |
| 2023 | Dec 29, 2023 | $40.64M | -30.2% |
| 2022 | Dec 30, 2022 | $58.26M | +76.3% |
| 2021 | Jan 29, 2021 | $33.04M | +5.3% |
| 2020 | Dec 31, 2020 | $31.39M | – |
See a number that looks wrong?